This talk contends that China’s approach to developing biotechnology centers on the principle of “technological domestication”, whereby social anxieties surrounding genetically modified technology are recast as an opposition to foreign aggressors, be they countries, companies, or individual actors. This nationalist frame is a principle of institution building, generating not only distinctly “Chinese” technologies, but also new ethical frameworks, modalities of social order, and ontologies of state, science, and market collaboration. In this talk, I focus on how these dynamics drive the emergence of unique organizational forms and entrepreneurial strategies in China’s domestic agrobiotechnology industry. I show that solidifying the salience of national boundaries enables the emergence of organizational forms that transcend the boundaries between state-owned/private and academic/commercial entities. Chinese biotech firms are akin to Schrodinger’s cat, simultaneously occupying plural states and defining themselves as different organizational “types” once context is specified. I call this phenomenon “organizational chimerism”. This ability to inhabit a dualistic, “chimeric” state, in turn, is leveraged by individual firms, entrepreneurs, and local state officials as they navigate a system characterized by competing logics and high levels of uncertainty. Ultimately, however, the very characteristics optimizing firm’s performance within China’s domestic knowledge economy also contribute to these companies’ “domestication” by the state.